Sign inJoin waitlistJoin the waitlist

Barry Maurer

Faculty Member · Texas Tech University Health Sciences Center at Lubbock

Credentials: · · ·

History

Pediatrics

Research

Retinoid therapy of high-risk neuroblastoma
Review · Cancer Letters · 2003 · Last of 4 authors · 277 citations
Ceramide synthesis and metabolism as a target for cancer therapy
Review · Cancer Letters · 2004 · 266 citations
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines
Journal of the National Cancer Institute · 1999 · First of 5 authors · 251 citations

JV
Judith Villablanca
3 papers
Katherine Matthay
3 papers
Araz Marachelian
2 papers
David Gandara
2 papers
Hiroyuki Shimada
2 papers
Jacek Pinski
2 papers
Martin Gutierrez
2 papers
MS
Michael Song
2 papers · 1 as a resident
Shivaani Kummar
2 papers
Alexander Towbin
1 paper · 1 as a fellow
Alexis Boulter
1 paper · 1 as a fellow
AH
Allan Haynes
1 paper

Grants

Novel L-Threo-Sphinganines for Ceramides-Based Cancer Therapy
National Cancer Institute · R15
Contact PI · $443.6K · Texas Tech University Health Scis Center
2012–2014
Novel Ceramide-Based Chemotherapy for Acute Leukemia
National Cancer Institute · R01
Contact PI · $980.3K · Texas Tech University Health Scis Center
2004–2010
PPMP as a Ceramide Catabolism Inhibitor for Chemotherapy
National Cancer Institute · R41
Contact PI · $249.9K · Avanti Polar Lipids, Inc.
2003–2004

Clinical trials

N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Study chair · Completed · Phase 1
New Approaches to Neuroblastoma Therapy Consortium
2006–2012
N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Study chair · Completed · Phase 1
New Approaches to Neuroblastoma Therapy Consortium
2005–2015